SVRA
Savara Inc
Key Financials
Gross Profit
$2.0M
0.0%
Operating Income
$-123547000
↓ 19.7%
Net Income
$-118837000
↓ 23.9%
Revenue
$257000
0.0%
EPS (Diluted)
$-0.53
↓ 10.4%
Total Liabilities
$50.3M
↑ 21.4%
Total Assets
$253.4M
↑ 19.1%
Shareholders' Equity
$203.1M
↑ 18.5%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| PRE 14A | 4/10/2026 | View on SEC |
| 4 | 3/20/2026 | View on SEC |
| 8-K | 3/13/2026 | View on SEC |
| 10-K | 3/13/2026 | View on SEC |
| SCHEDULE 13G/A | 2/17/2026 | View on SEC |
| 4 | 2/17/2026 | View on SEC |
| SCHEDULE 13G/A | 2/17/2026 | View on SEC |
| SCHEDULE 13G/A | 2/13/2026 | View on SEC |
| SCHEDULE 13G/A | 2/13/2026 | View on SEC |
| SCHEDULE 13G/A | 2/5/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | SVRA |
| Company Name | Savara Inc |
| CIK | 1160308 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 51285113796 |